• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Cancer Detection

Flatiron Health and Lifebit Partner to Enhance Cancer Care in Japan through Real-World Data

by Syed Hamza Sohail 10/08/2024 Leave a Comment

Flatiron Health and Lifebit Partner to Enhance Cancer Care in Japan through Real-World Data

What You Should Know: -  Flatiron Health, and Lifebit Biotech Ltd (UK, London; hereafter “Lifebit”), are expanding their collaboration into Japan to transform cancer care, facilitating ground breaking research by allowing for safe and secure access to real-world data (RWD). - Building on the success of their multi-year strategic partnership, Lifebit’s pioneering federated Trusted Research Environment (TRE) technology will enable safe and secure access to Flatiron Health’s high-quality
Read More

CancerIQ Raises Growth Capital for Personalized Cancer Detection

by Fred Pennic 08/21/2024 Leave a Comment

CancerIQ Raises Growth Capital for Personalized Cancer Detection

What You Should Know:  - CancerIQ, a Chicago, IL-based precision health platform focused on empowering healthcare providers to personalize cancer prevention and early detection announced it has secured a growth funding package from Decathlon Capital Partners.  - While specific financial details of the transaction were not disclosed, the investment will enable CancerIQ to further develop its digital tools, introduce new offerings, and strengthen partnerships with healthcare
Read More

PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments

by Fred Pennic 08/21/2024 Leave a Comment

PreciseDx Raises $20.7M for AI-Powered Cancer Risk Assessments

What You Should Know:  - PreciseDx, a pioneering company in oncology diagnostics utilizing artificial intelligence (AI) raises $20.7M in Series B funding led by Eventide Asset Management with participation from Labcorp, Quest Diagnostics, GenHenn Capital Venture, and existing investors. This brings the company's total funding to date to $31.5M.  - The new funding will enable PreciseDx to accelerate its growth and expand its operations. The company plans to invest in talent
Read More

Color Health Expands Cancer Screening with SkinIO and Bexa Partnerships

by Jasmine Pennic 05/30/2024 Leave a Comment

Color Health Expands Cancer Screening with SkinIO and Bexa Partnerships

What You Should Know:  - Color Health, a leader in comprehensive cancer care, announced today that it is partnering with SkinIO and Bexa to integrate their innovative solutions for skin and breast cancer screening into its Virtual Cancer Clinic.  - The collaboration aims to significantly increase cancer screening and detection rates, making early diagnosis more accessible for employers and individuals. Bringing Cutting-Edge Screening to the Workplace and Beyond SkinIO: This
Read More

PathAI Unveils New AI-Powered Pathology Tools for Cancer Research

by Syed Hamza Sohail 05/30/2024 Leave a Comment

PathAI Unveils New AI-Powered Pathology Tools for Cancer Research

What You Should Know: -              PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights. -              The product pairing provides unprecedented single-cell and spatial resolution of
Read More

AccessHope Secures $33M to Expand Cancer Care Expertise

by Fred Pennic 04/22/2024 Leave a Comment

AccessHope Secures $33M to Expand Cancer Care Expertise

What You Should Know:  - AccessHope, a company revolutionizing how cancer patients receive cutting-edge treatment plans secures $33M in a Series B funding round led by City of Hope, a prominent cancer research and treatment organization.   - The company plans to use the investment to fuel AccessHope's next phase of growth as a standalone company. New CEO Bradley Kreick Takes the Helm To spearhead this growth trajectory, AccessHope has appointed seasoned healthcare
Read More

Culmination Bio, BillionToOne Partner to Validate Cancer Diagnostics

by Syed Hamza Sohail 04/04/2024 Leave a Comment

Culmination Bio, BillionToOne Partner to Validate Cancer Diagnostics

What You Should Know: Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all.Culmination Bio and BillionToOne are working together to leverage their respective strengths in order to facilitate the development and validation of robust and impactful oncology
Read More

Lunit Expands AI-powered Cancer Screening Solution to France and Portugal

by Jasmine Pennic 03/18/2024 Leave a Comment

Lunit Expands AI-powered Cancer Screening Solution to France and Portugal

What You Should Know: - Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion. - These strategic deals will bring Lunit's AI-powered cancer screening solution to healthcare providers in France and Portugal, aiding in the fight against cancer. TeleDiag and Lunit Partner to Improve Lung Cancer Detection in France Lunit has partnered with TeleDiag,
Read More

Veracyte Acquires C2i Genomics for $70M, Expanding into Minimal Residual Disease Detection

by Fred Pennic 01/09/2024 Leave a Comment

Veracyte Acquires C2i Genomics for $70M, Expanding into Minimal Residual Disease Detection

What You Should Know: - Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection. - Under the terms of the agreement, Veracyte will pay $70 million in Veracyte shares at closing, and up to an additional $25 million based on the achievement of future performance milestones over the next two years, payable in Veracyte shares or cash at Veracyte’s election. - This strategic move positions Veracyte to
Read More

Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer

by Fred Pennic 12/04/2023 Leave a Comment

Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer

What You Should Know: - Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer. - This partnership combines Absci's cutting-edge Integrated Drug Creation™ platform with AstraZeneca's oncology expertise, aiming to accelerate the discovery of a potential new cancer treatment. Absci's AI Engine Takes the Lead Absci will leverage
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |